Keywords: UK, NICE, GlaxoSmithKline, Trobalt, Epilepsy

UK’s NICE adds GlaxoSmithKline Trobalt as new NHS epilepsy option

Article | 29 July 2011

Print This

UK pharma major GlaxoSmithKline’s Trobalt (retigabine) has been recommended for use in the UK’s National Health ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in